Science Explorer Back to mapMap
Discussion
Topic · Dermatology

Dermatological and COVID-19 studies

Dermatological and COVID-19 studies is a research topic within Dermatology. Science Explorer counts 12k research works in it since 1950. 10.2% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the dermatologic manifestations of COVID-19, including cutaneous signs, chilblain-like lesions, pernio, oral manifestations, erythema nodosum, and vesicular rash. It includes histopathological studies and a comprehensive review of the various skin lesions associated with COVID-19.

  • COVID-19
  • Dermatologic Manifestations
  • Cutaneous Signs
  • Skin Lesions
  • Chilblain-like Lesions
  • Pernio
  • Oral Manifestations
  • Erythema Nodosum
  • Vesicular Rash
  • Histopathological Study
Research works
12k
fractional, since 1950
In the world top 10%
1.2k
per year above
Top-10% rate
10.2%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+13%
the tick is no change
Largest producer
United States
28% of the 10 largest, 2022-now
Dermatological and COVID-19 studies

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Dermatological and COVID-19 studies research?

By volume, the United States and India publish the most (664 and 399 works in 2022-now).

By volume, 2022-now

  1. 1 United States 664 works
  2. 2 India 399 works
  3. 3 China 238 works
  4. 4 Brazil 237 works
  5. 5 Türkiye 194 works
  6. 6 Italy 167 works
  7. 7 Spain 148 works
  8. 8 United Kingdom 122 works
  9. 9 Iran 121 works
  10. 10 Japan 121 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 27.5%India: 16.6%China: 9.9%Brazil: 9.8%6 others listed: 36.2%28%largest
United States664 · 27.5%India399 · 16.6%China238 · 9.9%Brazil237 · 9.8%6 others listed873 · 36.2%

Shares of the rows listed above, not of the whole node.

Which institutions lead Dermatological and COVID-19 studies research?

By volume in 2022-now, All India Institute of Medical Sciences publishes the most Dermatological and COVID-19 studies research, followed by Harvard University and Sağlık Bilimleri Üniversitesi.

By volume, 2022-now

  1. 1 All India Institute of Medical SciencesIndia 25 works
  2. 2 Harvard UniversityUnited States 23 works
  3. 3 Sağlık Bilimleri ÜniversitesiTürkiye 20 works
  4. 4 Tehran University of Medical SciencesIran 18 works
  5. 5 Universidade de São PauloBrazil 18 works
  6. 6 University of North Carolina at Chapel HillUnited States 16 works
  7. 7 Mayo ClinicUnited States 13 works
  8. 8 Banaras Hindu UniversityIndia 13 works
  9. 9 Post Graduate Institute of Medical Education and ResearchIndia 11 works
  10. 10 InsermFrance 11 works

Who are the leading researchers in Dermatological and COVID-19 studies?

The most-cited researchers publishing on Dermatological and COVID-19 studies include Gregory Y.H. Lip and Salim Yusuf.

  1. 1 Gregory Y.H. Lip United Kingdom 311k citations
  2. 2 Salim Yusuf Canada 294k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Dermatological and COVID-19 studies?

The most cited paper in Dermatological and COVID-19 studies is "APACHE II-A Severity of Disease Classification System" (William A. Knaus, Elizabeth A. Draper, Douglas P. Wagner et al., 1986), with 13,426 citations. Next come "Down-Regulation of Na+/K+ATPase Activity by Human Parvovirus B19 Capsid Protein VP1" (8,699) and "Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis" (4,454).

Most cited papers
#PaperReleasedCitations
1 APACHE II-A Severity of Disease Classification System William A. Knaus, Elizabeth A. Draper, Douglas P. Wagner et al. · Critical Care Medicine Aug 1986 13,426
2 Down-Regulation of Na+/K+ATPase Activity by Human Parvovirus B19 Capsid Protein VP1 Ahmad Almilaji, Kalina Szteyn, Evelyn Fein et al. · Cellular Physiology and Biochemistry Open access 2013 8,699
3 Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis Jing Yang, Ya Zheng, Xi Gou et al. · International Journal of Infectious Diseases ReviewOpen access 12 Mar 2020 4,454
4 Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China Jinjin Zhang, Xiang Dong, Yiyuan Cao et al. · Allergy Open access 20 Feb 2020 4,262
5 Measurement of Cutaneous Inflammation: Estimation of Neutrophil Content with an Enzyme Marker Peter P. Bradley, Dennis A. Priebat, Robert D. Christensen et al. · Journal of Investigative Dermatology Open access Mar 1982 3,644
All 100 most cited papers, with filters and sorting

Where is Dermatological and COVID-19 studies research done?

The largest centres of Dermatological and COVID-19 studies research in 2022-now are São Paulo (Brazil), Istanbul (Türkiye), Tehran (Iran) and Moscow (Russia).

Largest cities, 2022-now

  1. 1 São PauloBrazil 57 works
  2. 2 IstanbulTürkiye 55 works
  3. 3 TehranIran 50 works
  4. 4 MoscowRussia 42 works
  5. 5 ParisFrance 40 works
  6. 6 New DelhiIndia 40 works
  7. 7 New YorkUnited States 37 works
  8. 8 MadridSpain 32 works
  9. 9 BeijingChina 32 works
  10. 10 LondonUnited Kingdom 32 works
See Dermatological and COVID-19 studies on the map

Where is the best place to study Dermatological and COVID-19 studies?

Among universities, judged by research, Harvard University, Tehran University of Medical Sciences and University of Naples Federico II score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 18.7%fractional works in this field (log) →share of work in the world top 10% →University of Naples…Harvard UniversityTehran University of…All India Institute …
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 66.724.7%2.1×23 -21.1%
2Tehran University of Medical SciencesIran 63.118.7%8.9×18 +28.6%
3University of Naples Federico IIItaly 61.738.5%3.4×8 +22.1%
4All India Institute of Medical SciencesIndia 54.59.4%6.5×25 +11.2%
5Sağlık Bilimleri ÜniversitesiTürkiye 52.64.3%10.3×20 +40.2%
6Universidade de São PauloBrazil 52.211.8%2.5×18 +24.1%
7Tel Aviv UniversityIsrael 52.022.6%3.9×11 +32.3%
8University of BolognaItaly 48.024.8%2.9×8 +28.5%
9Central South UniversityChina 43.925.3%1.4×9 +58.4%
10University of North Carolina at Chapel HillUnited States 38.26.9%2.5×16 +184.2%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Dermatological and COVID-19 studies, country by country

Is Dermatological and COVID-19 studies research growing?

Output in 2022-2025 was 13% higher than in 2018-2021, peaking in 2021. The fastest-growing topics are Dermatological and COVID-19 studies.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Dermatological and COVID-19 studies as a percentage of every work published that year, 0.012% in 2024.

still counting0.010%0.020%0.030%Dermatological and COVID-19 studies0.012% in 202519801990200020102020

Fractional works of Dermatological and COVID-19 studies over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Dermatological and COVID-19 studies10.4% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Dermatological and COVID-19 studies. Posts are plain text and can be reported.